EBV-specific T-cell response and immunosuppression by methotrexate and TNFα antagonists in patients with chronic inflammatory joint disease

被引：1
|
作者：
Miceli-Richard, Corinne [1 ,2 ]
Marlette, Xavier [1 ,2 ]
机构：
[1] Hop Bicetre, AP HP Paris, Serv Rhumatol, Le Kremlin Bicetre, France
[2] Univ Paris Sud 11, Inst Sante Rech Med INSERM, U802, Le Kremlin Bicetre, France
来源：
JOINT BONE SPINE | 2007年 / 74卷 / 06期
关键词：
Epstein-Barr virus; TNF antagonists; methotrexate; lymphoma; T-cell response;
D O I：
10.1016/j.jbspin.2007.09.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：560 / 562
页数：3
相关论文
共 50 条
  • [1] Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome
    Loebel, Madlen
    Strohschein, Kristin
    Giannini, Carolin
    Koelsch, Uwe
    Bauer, Sandra
    Doebis, Cornelia
    Thomas, Sybill
    Unterwalder, Nadine
    von Baehr, Volker
    Reinke, Petra
    Knops, Michael
    Hanitsch, Leif G.
    Meisel, Christian
    Volk, Hans-Dieter
    Scheibenbogen, Carmen
    PLOS ONE, 2014, 9 (01):
  • [2] Dissecting EBV-specific T-cell responses after allogeneic EBV-specific T-cell transfer for CNS PTLD
    Maecker-Kolhoff, Britta
    Schultze-Florey, Rebecca E.
    Tischer, Sabine
    Kuhlmann, Leonie
    Hundsdoerfer, Patrick
    Koch, Arend
    Ravens, Sarina
    Goudeva, Lilia
    Schultze-Florey, Christian
    Koenecke, Christian
    Blasczyk, Rainer
    Koehl, Ulrike
    Heuft, Hans-Gert
    Prinz, Immo
    Eiz-Vesper, Britta
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 46 - 46
  • [3] Dissecting EBV-specific T-cell responses after successful allogeneic EBV-specific T-cell transfer for CNS PTLD
    Maecker-Kolhoff, Britta
    Schultze-Florey, Rebecca E.
    Tischer, Sabine
    Kuhlmann, Leonie
    Hundsdoerfer, Patrick
    Koch, Arend
    Ravens, Sarina
    Goudeva, Lilia
    Schultze-Florey, Christian
    Koenecke, Christian
    Blasczyk, Rainer
    Koehl, Ulrike
    Heuft, Hans-Gert
    Prinz, Immo
    Eiz-Vesper, Britta
    BONE MARROW TRANSPLANTATION, 2018, 53 : 220 - 221
  • [4] Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
    Jilek, Samantha
    Schluep, Myriam
    Meylan, Pascal
    Vingerhoets, Francois
    Guignard, Laurence
    Monney, Anita
    Kleeberg, Joerg
    Le Goff, Geraldine
    Pantaleo, Giuseppe
    Du Pasquier, Renaud A.
    BRAIN, 2008, 131 : 1712 - 1721
  • [5] EBV-specific T-cell immunity: relevance for multiple sclerosis
    Behrens, Malina
    Comabella, Manuel
    Luenemann, Jan D.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] EBV-induced T-cell responses in EBV-specific and nonspecific cancers
    Zhang, Qiuting
    Xu, Miao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
    Lee, SP
    SEMINARS IN CANCER BIOLOGY, 2002, 12 (06) : 463 - 471
  • [8] Off-the-shelf EBV-specific T-cell Immunotherapy for EBV-associated PTLD
    O'Reilly, Maeve
    Peggs, Karl S.
    TRANSPLANTATION, 2020, 104 (10) : 1972 - 1973
  • [9] Herpes zoster in patients taking TNFα antagonists for chronic inflammatory joint disease
    Wendling, Daniel
    Streit, Gerald
    Toussirot, Eric
    Prati, Clement
    JOINT BONE SPINE, 2008, 75 (05) : 540 - 543
  • [10] Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines
    Rooney, CM
    Aguilar, LK
    Huls, MH
    Brenner, MK
    Heslop, HE
    EPSTEIN-BARR VIRUS AND HUMAN CANCER, 2001, 258 : 221 - 229
12345